NCT05090072 (DAVPAL) is a NA clinical trial of Advance Directives in End-of-life, sponsored by Universidade do Porto.

Who is sponsoring NCT05090072?

NCT05090072 is sponsored by Universidade do Porto.

What drugs are being tested in NCT05090072?

Interventions in NCT05090072: Advance Directives, Control.

What condition does NCT05090072 study?

NCT05090072 studies End-of-life.

Is NCT05090072 still recruiting?

NCT05090072 is currently completed. Last updated 17 March 2022.

Last reviewed 2022-03-17 · How we verify

NCT05090072: DAVPAL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Advanced Directives in Palliative Care (DAVPAL)

Completed NA Last updated 17 March 2022

What this trial tests

NA trial testing Advance Directives in End-of-life in 116 participants. Completed in 30 April 2021.

Timeline

10 September 2018

Primary endpoint
23 August 2019

30 April 2021

Quick facts

Lead sponsor	Universidade do Porto
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	116
Start date	10 September 2018
Primary completion	23 August 2019
Estimated completion	30 April 2021
Sites	1 location across Portugal

Drugs / interventions tested

Advance Directives
Control

Conditions studied

End-of-life — all drugs for End-of-life →

Sponsor

Universidade do Porto — full company profile →

Who can join

18 and older, any sex, with End-of-life. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective, single-blinded, controlled, and randomized trial to find if physician's use of the Portuguese Advance Directives, in palliative care, as a communication tool between patients and caregivers, improves the agreement and reliability between patients and their health surrogates, in their decisions about end-of-life care.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Do surrogates predict patient preferences more accurately after a physician-led discussion about advance directives? A randomized controlled trial.
Martins CS, Sousa I, Barros C, Pires A, et al · · 2022 · cited 4× · PMID 35820845 · DOI 10.1186/s12904-022-01013-3
Advanced directives' knowledge among Portuguese palliative patients and caregivers: do the sociodemographic factors influence it? A cross-sectional survey.
Martins CS, Nunes R. · · 2023 · cited 3× · PMID 37393243 · DOI 10.1186/s12904-023-01203-7
Portuguese Advance Directives-a twist against futility? A cross sectional study.
Martins CS, Nunes R. · · 2024 · cited 1× · PMID 38536997 · DOI 10.1590/1516-3180.2022.0537.r2.201023
Advanced Directives’ Knowledge in Palliative Care: Do the Sociodemographic Features Influence it? A Survey in a Portuguese Population.
Martins CS, Nunes R. · · 2022 · DOI 10.21203/rs.3.rs-1881046/v1

Verify or expand the search:

Other trials of Advance Directives

Trials testing the same drug.

NCT02702284 — Advance Directives Completion Rates and an Intervention to Address Health Literacy in a Clinic Population · NA · completed

Other Universidade do Porto trials

Trials by the same sponsor.

NCT07457697 — MyGENESIS: A Digital Psychoeducational Program for Donor-Conceived Young Adults · NA · not yet recruiting
NCT07503990 — Effects of Food Intake Sequence on Substrate Utilisation and Endurance Performance · NA · recruiting
NCT07436091 — Porcine Derma for Soft Tissue Augmentation Around Implants · NA · not yet recruiting
NCT07498556 — Immediate Restoration of a New Implant With High Primary Stability · NA · not yet recruiting
NCT07448870 — Evaluating the Mentalization-based Treatment Lighthouse Parenting Programme: Protocol of a Feasibility and Acceptability · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05090072 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidade do Porto
Last refreshed: 17 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05090072.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing